Understanding Kallikrein 6 in Ovarian Cancer
Author Information
Author(s): Ni X, Zhang W, Huang K-C, Wang Y, Ng S-K, Mok S C, Berkowitz R S, Ng S-W
Primary Institution: Brigham and Women's Hospital
Hypothesis
Kallikrein 6 may serve as a biomarker for early detection of ovarian cancer.
Conclusion
Kallikrein 6 is highly expressed in various subtypes of ovarian tumors and may be useful for early detection.
Supporting Evidence
- Kallikrein 6 is significantly overexpressed in ovarian tumor cells compared to normal ovarian epithelium.
- High expression of kallikrein 6 was observed in both borderline and invasive ovarian tumors.
- Gene amplification may contribute to the elevated expression of kallikrein 6 in some ovarian tumors.
Takeaway
This study found that a protein called kallikrein 6 is found in high amounts in ovarian cancer, which could help doctors find the cancer earlier.
Methodology
The study involved immunohistochemistry and quantitative real-time PCR to analyze kallikrein 6 expression in ovarian tissues.
Limitations
The study primarily focused on specific tumor types and may not represent all ovarian cancer cases.
Participant Demographics
The study included women undergoing surgery for ovarian cancer and control subjects with benign conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website